Title: Breast Cancer Therapeutics in Asia-Pacific Markets to 2021
1Breast Cancer Therapeutics in Asia-Pacific
Markets to 2021 - Growth Driven by Increasing
Uptake of Premium Priced Biologics and Rising
Prevalence
To buy this Report Visit http//www.jsbmarketresea
rch.com
2Summary
- Breast cancer, a malignant neoplasm, is the
second-most common - cancer and the most common cancer in women
worldwide, - accounting for 16 of all female cancers, making
the disease - exceedingly prevalent. In the past, breast cancer
occurred less in - women in Asia than women in Western countries.
However, recent - studies show that breast cancer is being
diagnosed more - frequently in women living in Asia, especially
among younger - women.
- The marketed products landscape comprises a wide
range of - treatment options, including hormonal therapies,
chemotherapies, - combination therapies and targeted therapies.
g
3 Scope
- The current breast cancer market contains novel
products, including - Perjeta, a targeted therapy Kadcyla, a human
antibody-drug conjugate - and Halaven, a novel chemotherapeutic agent. -
What are the competitive advantages of the
existing novel drugs? - Are these targeted
therapies used to the same magnitude in all the
countries assessed? - What are the factors
contributing to the uptake of these drugs in each
country? With over 700 active pipeline
molecules, most of the investigational drug
candidates are being evaluated for the first-line
or second-line treatment of advanced-stage breast
cancer, featuring new combination therapies,
targeted therapies, and promising
immunotherapies, as well as chemotherapy drug
candidates.
g
4 Reasons to buy
- This report will enable you to -
- Understand the clinical context of breast cancer
by considering symptoms, etiology,
pathophysiology, epidemiology, diagnosis, and
treatment options - - Identify the therapeutic strategies, products,
and companies that dominate the current marketed
products landscape and recognize gaps and areas
of unmet need - - Identify key pipeline trends in molecule type,
administration route, mechanism of action, and
novelty - - Consider market opportunities and potential
risks by examining trends in breast cancer
clinical trial size, duration, and failure rate
by stage of development, molecule type, and
mechanism of action
g
5Table Of Content
2 Introduction 9 2.1 Disease Introduction
9 2.2 Symptoms 10 2.3 Etiology 10 2.4
Pathophysiology 11 2.5 Epidemiology 12 2.6
Diagnosis and Classification 14 2.7 Prognosis
and Disease Staging 16 2.8 Treatment Options
18 2.8.1 Surgery and Radiation Therapy 18 2.8.2
Chemotherapy 19 2.8.3 Hormonal Therapies
19 2.8.4 Targeted Therapies 20 2.8.5 Resistance
to Pharmacological Therapies 20 2.9 Treatment
Guidelines 21
g
6Related Market Research Report
- Hormone Refractory Breast Cancer-Pipeline
Insights, 2016US - Breast Cancer Imaging Industry 2015 Market
Research - Global Breast Cancer Imaging Industry 2015 Market
Research ReportReport - Breast Cancer Treatment Drug Companies in China
- Breast Cancer Treatment Drug Industry Forecasts -
China Focus - Breast Cancer Treatment Drug Markets in China
- Metastatic Breast Cancer - Pipeline Review, H1
2015
g
7 About JSB Market Research
- JSBMarketResearch.Com is an online repository of
an extensive collection of market - research reports available online. This online
portal contains high quality reports - with well-researched and high quality content on
a wide range of industries. These - market research reports help us give a detailed
insight into new opportunities in - The industry, prevailing market trends,
competitor analysis and future - prospects.
- JSBs reports are developed by the domain experts
and publishers under a closely - observed surveillance of industry specialists in
Online Database.Therefore, the - researched data is well researched, well-
organized and matching up to the best - standards in the industry. Also JSBs database
consists of detailed insights of the - leading players in the global market, products
and trends also find latest updates on - global conference events.
g
8To Know More
- http//www.jsbmarketresearch.com/healthcare-medica
l/r-breast-cancer-therapeutics-in-asia-pacific-mar
kets-151132 - Contact Details
- JSB Market Research
- Phone 91 - 998 729 5242
- Email - enquiry_at_jsbmarketresearch.com
- Website http//www.jsbmarketresearch.com
g